IGEL has reached a valuation exceeding $1 billion following a strategic investment from Vitruvian Partners. Vitruvian will join existing investor TA Associates in supporting the endpoint security software company’s product development and international expansion. Financial terms were not disclosed.
The deal is expected to close during the first quarter of 2027, subject to regulatory approvals.
Endpoint Security And Resilience
IGEL provides an endpoint platform covering preventative security, business continuity, disaster recovery, and operational technology.
Its platform begins with an immutable operating system intended to limit the endpoint attack surface and reduce local data exposure. Centralized governance and contextual controls support access to cloud services, virtual desktops, enterprise browsers, software-as-a-service applications, and other compatible systems.
IGEL’s business continuity and disaster recovery technology provides a recovery path for supported Windows endpoints affected by ransomware, outages, and other disruptions.
The company also applies its security and centralized-management model to manufacturing and operational environments where availability is critical.
IGEL reported annual recurring revenue growth exceeding 40% during the past year. It plans to invest in product innovation, partner development, and global expansion.
KEY QUOTES:
Enterprises and governments need a trusted endpoint platform that helps them prevent disruption and keep their businesses operating. Our growing adoption by large international enterprises and governments demonstrates both the strength of our technology and the scale of the opportunity ahead. Together with Vitruvian and TA, we believe we are positioned to accelerate our global expansion and establish IGEL as an essential platform for enterprises and entire countries’ security and resilience strategy.
Klaus Oestermann, CEO of IGEL
IGEL sits at the center of a structural shift in enterprise cybersecurity. As the threat landscape continues to evolve, enterprises are increasingly seeing immutable endpoints as a critical component of their Zero Trust strategy. With its leading product suite across endpoint OS, BC&DR and OT, we believe IGEL has a unique opportunity to capitalize on these tailwinds.
Jack Alcock, Partner at Vitruvian Partners
With its mission-critical software and its exceptional leadership team, IGEL is well-placed to continue its global expansion. Vitruvian brings extensive experience of supporting European market leaders in their global ambitions and we look forward to working with Klaus and his team, alongside TA, to accelerate the Company’s international growth.
Tassilo Arnhold, Partner at Vitruvian Partners
Since TA’s initial investment in 2021, IGEL has expanded its platform, increased operational and developmental bandwidth, and strengthened its global presence. In a time of rapid digital transformation, we remain confident in IGEL’s strategy and its ability to help customers modernize securely. We are pleased to welcome Vitruvian and look forward to working together alongside IGEL management to support IGEL’s continued growth journey.
Stefan Dandl, Managing Director at TA Associates, and John Meeks, Senior Advisor at TA Associates

